Rehabilitation Robots Market Analysis

Type (Assistive, Therapeutic, Surgical, Exoskeleton Robot)

The exoskeleton robot segment is poised to dominate the global rehabilitation robots market by registering a CAGR of 38% in the time period between 2023-2036. Exoskeletons are designed to accelerate human strength and other medical capabilities. The increasing number of patients with physical movement disorders such as Parkinson's disease, stroke, etc. is a major factor accelerating the demand for exoskeletons as these diseases limit voluntary body movements and cause problems in daily routine activities. Robotic exoskeletons are emerging as rehabilitation tools to improve a variety of health-related outcomes after spinal cord injury. For instance, ReWalk is the first exoskeleton to receive FDA clearance for rehabilitation use in the United States. This robotic exoskeleton enables people with spinal cord injuries to stand, walk, roll over, and climb.  

End-User (Hospital, Orphanage, Nursing Home)

The hospital segment in the rehabilitation robots market is set to hold the largest revenue share of 48% by the end of 2036. This growth is primarily due to rising healthcare costs and the rapid adoption of advanced technology in healthcare facilities. Additionally, a large population with musculoskeletal disorders, spinal cord injuries, etc. tend to move to hospitals for rehabilitation therapy, fueling the growth of this segment. 

Our in-depth analysis of the global market includes the following segments: